BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 241 filers reported holding BEAM THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 1.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $874 | -20.0% | 36,325 | +6.1% | 0.00% | – |
| Q2 2023 | $1,093 | +16.6% | 34,225 | +12.0% | 0.00% | – |
| Q1 2023 | $937 | -19.1% | 30,569 | +3.3% | 0.00% | – |
| Q4 2022 | $1,158 | -99.9% | 29,598 | +9.4% | 0.00% | – |
| Q3 2022 | $1,289,000 | +41.8% | 27,045 | +15.2% | 0.00% | – |
| Q2 2022 | $909,000 | -27.7% | 23,485 | +7.1% | 0.00% | – |
| Q1 2022 | $1,257,000 | -16.1% | 21,936 | +16.7% | 0.00% | – |
| Q4 2021 | $1,498,000 | -25.8% | 18,800 | -18.9% | 0.00% | – |
| Q3 2021 | $2,018,000 | -39.4% | 23,193 | -10.4% | 0.00% | – |
| Q2 2021 | $3,332,000 | -19.7% | 25,884 | -50.1% | 0.00% | – |
| Q1 2021 | $4,148,000 | +398.6% | 51,823 | +408.4% | 0.00% | – |
| Q4 2020 | $832,000 | -93.3% | 10,193 | -97.7% | 0.00% | -100.0% |
| Q2 2020 | $12,445,000 | +51.5% | 444,449 | -2.6% | 0.00% | +100.0% |
| Q1 2020 | $8,216,000 | – | 456,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,362,635 | $304,095,000 | 29.88% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 224,391 | $28,881,000 | 22.15% |
| HSG Holding Ltd | 796,089 | $102,465,000 | 7.14% |
| DC Investments Management, LLC | 21,010 | $2,704,000 | 6.36% |
| PATHWAY CAPITAL MANAGEMENT, LP | 112,197 | $14,441,000 | 5.74% |
| Redmile Group, LLC | 2,052,506 | $264,178,000 | 3.91% |
| Casdin Capital, LLC | 818,820 | $105,390,000 | 2.68% |
| Darwin Global Management, Ltd. | 126,985 | $16,344,000 | 2.64% |
| Evolutionary Tree Capital Management, LLC | 44,032 | $5,667,000 | 2.61% |
| HHLR ADVISORS, LTD. | 1,845,753 | $237,567,000 | 2.44% |